Capvizr
News · All summaries
Healthcare & Life Sciences
Heaviside Industries
Series B$60 million
RoundSeries B
Amount$60 million
LeadKhosla Ventures
HQCambridge, United States
DateAugust 12, 2026
THE DEAL, AT A GLANCE

Heaviside Industries

From the announcement
Who is involvedBacked by Khosla Ventures, bringing, Stealth with $28M Series AFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedHeaviside Industries raised $60M Series B, announced 2026-08-12From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersHeaviside Industries' Series B supports an in vivo CAR therapy strategy for autoimmune disease and oncology using an mRNA-LNP platform.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Heaviside Industries · Financing Record

Explore source-linked visual explanations for Heaviside Industries. Unsupported claims are withheld while source review continues.

Record 10120 · Recorded date: 2026-08-12

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime